FDA approves Xofluza to treat influenza in those at high risk of influenza complications Oct. 18, 2019
New potent and selective ROS1/TRK family inhibitor is effective in crizotinib-resistant models Oct. 18, 2019
TAP downregulation by an aptamer-siRNA conjugate could potentiate responsiveness to immune therapy Oct. 18, 2019
Shanghai Institute of Materia Medica and Jinan University patent AXL and/or FLT3 inhibitors Oct. 18, 2019
New apoptosis regulator Bcl-2 inhibitors disclosed by Jiangsu Chia Tai Tianqing Pharmaceutical Group Oct. 18, 2019
RSS